Award recordCONTRACT

ACTELION PHARMACEUTICALS US, INC.

PIID VA671A20008· VHA· 674-TEMPLE· 6505 · DRUGS AND BIOLOGICALS· FY2012· $288,091 net obligations· UEI H5BMHLMMNA28· CA

Description

MODIFICATION TO ADD FUNDS FOR FY 12

Base award description: TRACLEER

First action · last action
2011-10-01 · 2013-03-22
Transactions
3
First transaction's obligation
$210,000
Base + all options value (sum of deltas)
$498,091
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5160B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$310,800$0Base award · 2011-10-01 · this action $210,000 · running total $210,000Modification P00001 · 2012-07-20 · this action $100,800 · running total $310,800Modification P00002 · 2013-03-22 · this action -$22,709 · running total $288,091
  • Base2011-10-01+$210,000= $210,000
  • Mod P000012012-07-20+$100,800= $310,800
  • Mod P000022013-03-22-$22,709= $288,091
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-10-01+$210,000$210,000TRACLEER
Mod P00001· OTHER ADMINISTRATIVE ACTION2012-07-20+$100,800$310,800MODIFICATION TO ADD FUNDS FOR FY 12
Mod P00002· FUNDING ONLY ACTION2013-03-22−$22,709$288,091MODIFICATION TO ADD FUNDS FOR FY 12

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H5BMHLMMNA28)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0477245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$47,052FY2026
36C24526N0181245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$22,235FY2026
36C26026F0024260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$65,500FY2026
36C26026F0017260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$406,538FY2026
36C26025F0209260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$197,168FY2025
36C26025F0107260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$70,630FY2025

Other recipients under 6505 from 674-TEMPLE (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25714J2144LANTHEUS MEDICAL IMAGING, INC.674-TEMPLE$4,416FY2014
VA25713P2643PARTSSOURCE INC674-TEMPLE$5,000FY2013
VA25713F0034CSL BEHRING L.L.C.674-TEMPLE$60,660FY2013
VA25713F0016BAXTER HEALTHCARE CORPORATION674-TEMPLE$8,008FY2013
VA25712C0111CARDINAL HEALTH 414, LLC674-TEMPLE$369,880FY2013

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA671A20008_3600_V797P5160B_3600 · retrieved 2026-09-26.